Our proteomic analyses support a model where sustained DDR1 activation upon collagen deposition at the tumour front or at the metastatic niche maintains a high level of β‐catenin transcriptional activity necessary for cancer stem cells dissemination and survival. The gene discussed is DDR1; the disease is cancer.